Treatment For Cancer May No Longer Be As Grim As The Disease

October 07, 1998

Cauterising tumours with radio waves may provide a less invasive alternative to surgery for liver cancer and many other types of tumour, say two cancer specialists. Surgery to remove a tumour can prevent cancer spreading throughout the body. But in some cases, doctors decide not to operate, perhaps because the tumour is too close to an artery or because the patient is too weak to survive the operation. Sometimes chemotherapy can be used to kill the tumour cells. But these drugs kill healthy cells, too, and can make the patient feel very ill.

So radiologist John McGahan and oncologist Philip Schneider of the University of California at Davis are developing another alternative treatment, which is known as radio-frequency ablation. It involves heating the diseased cells with a fine electrode, and is similar to the traditional technique for cauterising blood vessels. "Essentially, we are hard-boiling the tissue," says Schneider. To treat liver cancers, the researchersinsert a flexible catheter through a patient's abdomen, using an ultrasound scan to guide it into position against the tumour. They then run a cluster of eight to ten wires through the catheter. When the wires reach the end of the tube, they fan out and penetrate the tumour.

A very high-frequency current in the wires causes nearby atoms to vibrate, heating the tissue from within just as a microwave cooker heats food. It takes ten minutes to kill all the cells in a region measuring 3 to 5 centimetres across. The technique can be used to destroy up to five liver tumours in a single session. Patients receiving this treatment can leave hospital much sooner than those who undergo conventional surgery. However, radio-frequency ablation does have serious side effects. The liver contains many biochemically active substances that leak into the body from the dead cells. As a result, patients may become feverish or nauseous. "They feel like they have the flu," says McGahan. And if the treatment damages nerves near the liver's surface, patients may feel chest or abdominal pain for up to a week.

The California team have so far tested their treatment on a dozen patients. Nine of the twelve have been free of cancer for more than a year. Left untreated, liver cancer is invariably fatal. Schneider expects that several more years of evaluation will be needed before the procedure becomes common. McGahan says radio-frequency ablation could treat benign tumours as well as cancer. For example, he recently removed a painful bone tumour from a girl's leg by inserting the wire through a small hole in her femur.

Param Sharma, an electrophysiologist at the University of Arizona, says radio-frequency ablation is already widely used to treat certain heart arrhythmias by destroying wayward pacemaker cells. He says there is no reason it couldn't be used for other tissue-killing procedures as well. "You can make a lesion any-where."

Author: Jonathan Knight, San Francisco
New Scientist issue 10th October 1998


New Scientist

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to